Literature DB >> 18791410

Thirty-two-channel coil 3T magnetic resonance-guided biopsies of prostate tumor suspicious regions identified on multimodality 3T magnetic resonance imaging: technique and feasibility.

Thomas Hambrock1, Jurgen J Fütterer, Henkjan J Huisman, Christina Hulsbergen-vandeKaa, Jean-Paul van Basten, Inge van Oort, J Alfred Witjes, Jelle O Barentsz.   

Abstract

OBJECTIVES: To test the technique and feasibility of translating tumor suspicious region maps in the prostate, obtained by multimodality, anatomic, and functional 3T magnetic resonance imaging (MRI) data to 32-channel coil, T2-weighted (T2-w), 3T MR images, for directing MR-guided biopsies. Furthermore, to evaluate the practicability of MR-guided biopsy on a 3T MR scanner using a 32-channel coil and a MR-compatible biopsy device.
MATERIALS AND METHODS: Twenty-one patients with a high prostate-specific antigen (>4.0 ng/mL) and at least 2 prior negative transrectal ultrasound-guided biopsies of the prostate underwent an endorectal coil 3T MRI, which included T2-w, diffusion weighted and dynamic contrast enhanced MRI. From these multimodality images, tumor suspicious regions (TSR) were determined. The 3D localization of these TSRs within the prostatic gland was translated to the T2-w MR images of a subsequent 32-channel coil 3T MRI. These were then biopsied under 3T MR guidance.
RESULTS: In all patients, TSRs could be identified and accurately translated to subsequent 3T MR images and biopsied under MR guidance. Median MR biopsy procedure time was 35 minutes. Of the 21 patients, 8 (38%) were diagnosed with prostate cancer, 6 (29%) had evidence of prostatitis, 6 (29%) had combined inflammatory and atrophic changes, and only 1 (5%) patient had no identifiable pathology.
CONCLUSIONS: Multimodality, 3T MRI determined TSRs could effectively be translated to T2-weighted images, to be used for MR biopsies. 3T MR-guided biopsy based on these translated TSRs was feasible, performed in a clinical useful time, and resulted in a high number of positive results.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18791410     DOI: 10.1097/RLI.0b013e31817d0506

Source DB:  PubMed          Journal:  Invest Radiol        ISSN: 0020-9996            Impact factor:   6.016


  29 in total

1.  MRI-guided prostate biopsy detects clinically significant cancer: analysis of a cohort of 100 patients after previous negative TRUS biopsy.

Authors:  M Roethke; A G Anastasiadis; M Lichy; M Werner; P Wagner; S Kruck; Claus D Claussen; A Stenzl; H P Schlemmer; D Schilling
Journal:  World J Urol       Date:  2011-04-22       Impact factor: 4.226

2.  [Standardised scoring of a multi-parametric 3-T MRI for a targeted MRI-guided prostate biopsy].

Authors:  C Arsov; D Blondin; R Rabenalt; G Antoch; P Albers; M Quentin
Journal:  Urologe A       Date:  2012-06       Impact factor: 0.639

3.  Image registration for targeted MRI-guided transperineal prostate biopsy.

Authors:  Andriy Fedorov; Kemal Tuncali; Fiona M Fennessy; Junichi Tokuda; Nobuhiko Hata; William M Wells; Ron Kikinis; Clare M Tempany
Journal:  J Magn Reson Imaging       Date:  2012-05-29       Impact factor: 4.813

Review 4.  Dynamic contrast-enhanced magnetic resonance imaging and pharmacokinetic models in prostate cancer.

Authors:  Tobias Franiel; Bernd Hamm; Hedvig Hricak
Journal:  Eur Radiol       Date:  2010-12-24       Impact factor: 5.315

5.  [Magnetic resonance tomography-guided interventional procedure for diagnosis of prostate cancer].

Authors:  M Schernthaner; T H Helbich; B J Fueger; M Margreiter; M Memarsadeghi; A Stiglbauer; H-G Linhart; A Doan; K Pinker; P Brader
Journal:  Radiologe       Date:  2011-11       Impact factor: 0.635

6.  Configurable automatic detection and registration of fiducial frames for device-to-image registration in MRI-guided prostate interventions.

Authors:  Junichi Tokuda; Sang-Eun Song; Kemal Tuncali; Clare Tempany; Nobuhiko Hata
Journal:  Med Image Comput Comput Assist Interv       Date:  2013

7.  Magnetic resonance sentinel lymph node imaging of the prostate with gadofosveset trisodium-albumin: preliminary results in a canine model.

Authors:  Baris Turkbey; Robert F Hoyt; Harsh K Agarwal; Marcelino Bernardo; Sandeep Sankineni; Linda Johnson; Kinzya B Grant; Soroush Rais-Bahrami; Hisataka Kobayashi; Bradford J Wood; Peter A Pinto; Gary L Griffiths; Peter L Choyke
Journal:  Acad Radiol       Date:  2015-02-13       Impact factor: 3.173

8.  Prostate MRI: diffusion-weighted imaging at 1.5T correlates better with prostatectomy Gleason Grades than TRUS-guided biopsies in peripheral zone tumours.

Authors:  Leonardo Kayat Bittencourt; Jelle O Barentsz; Luiz Carlos Duarte de Miranda; Emerson Leandro Gasparetto
Journal:  Eur Radiol       Date:  2011-09-14       Impact factor: 5.315

9.  Open-Source Platform for Prostate Motion Tracking During in-Bore Targeted MRI-Guided Biopsy.

Authors:  Peter A Behringer; Christian Herz; Tobias Penzkofer; Kemal Tuncali; Clare M Tempany; Andriy Fedorov
Journal:  Clin Image Based Proced       Date:  2016-03-23

Review 10.  Multidisciplinary functional MR imaging for prostate cancer.

Authors:  Jeong Kon Kim; Yun-Jin Jang; Gyunggoo Cho
Journal:  Korean J Radiol       Date:  2009 Nov-Dec       Impact factor: 3.500

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.